Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2012
03/15/2012WO2012033952A1 3 - phenyl- 2 -oxo- 1, 3 -oxazolidines for treatment of bacterial infections
03/15/2012WO2012033736A1 Novel piperazine analogs as broad-spectrum influenza antivirals
03/15/2012WO2012033548A2 Herbicidal bis-nitrogen-containing oxo and sulfono heterocycles
03/15/2012WO2012033195A1 Heterocyclic compound
03/15/2012WO2012033070A1 Therapeutic agent for pain
03/15/2012WO2012033069A1 Prostaglandin d synthase inhibitory piperidine compounds
03/15/2012WO2012032533A2 Processes for the preparation of 4-{4-[5(s)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl} morpholin-3-one
03/15/2012WO2012032067A1 Polymorphs and salts of n- [5- [4- (5- { [(2r,6s) -2, 6 - dimethyl - 4 -morpholinyl] methyl} - 1, 3 - oxazol - 2 - yl) - 1h- inda zol-6-yl] -2- (methyloxy) - 3 - pyridinyl] methanesulfonamide
03/15/2012WO2012032018A1 Heteroarylmethyl amides
03/15/2012WO2012012307A9 Sulfonyl compounds which modulate the cb2 receptor
03/15/2012WO2011147951A8 Cycloamino derivatives as gpr119 agonists
03/15/2012US20120065212 Heteroarylmethyl amides
03/15/2012US20120065205 Pyrazine carboxamide orexin receptor antagonists
03/15/2012US20120065204 Novel n-hydroxy-benzamids for the treatment of cancer
03/15/2012US20120065199 Substituted quinolines for use as vegf inhibitors
03/15/2012US20120065197 Pyridinylcarboxylic Acid Derivatives as Fungicides
03/15/2012US20120065196 Amide compounds
03/15/2012US20120065195 Compounds for treating neurodegenerative diseases
03/15/2012US20120065191 Pharmaceutical compounds
03/15/2012US20120065188 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065173 Chemical compounds
03/15/2012US20120065170 Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
03/15/2012US20120065168 Pharmaceutical Hypocholesterolemic Compositions
03/15/2012US20120065064 Novel herbicides
03/15/2012US20120064181 P2X3 Receptor Antagonists for Treatment of Pain
03/15/2012US20120064121 Pyridine compounds for inflammation and immune-related uses
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012US20120064025 Quinazolinone Modulators Of Nuclear Receptors
03/15/2012CA2810489A1 Prostaglandin d synthase inhibitory piperidine compounds
03/15/2012CA2810478A1 Processes for the preparation of 4-{4-[5(s)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one
03/15/2012CA2809778A1 Therapeutic agent for pain
03/15/2012CA2809624A1 Novel piperazine analogs as broad-spectrum influenza antivirals
03/15/2012CA2808665A1 Heteroarylmethyl amides
03/14/2012EP2428509A1 Human adam-10 inhibitors
03/14/2012EP2428508A1 Diamino heterocyclic carboxamide compound
03/14/2012EP2428507A2 Cannabinoid receptor ligands
03/14/2012EP2427458A1 Isoxazole-pyridazine derivatives
03/14/2012EP2427457A1 Isoxazole-pyridine derivatives as gaba modulators
03/14/2012EP2427456A1 Isoxazole-pyridine derivatives
03/14/2012EP2427455A1 Isoxazole-pyrazole derivatives
03/14/2012EP2427453A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
03/14/2012EP2427444A1 Inhibitors of the renal outer medullary potassium channel
03/14/2012EP2427441A1 Pmk2 modulators for use in the treatment of cancer
03/14/2012EP2427437A1 Dihydropyrimidinones for use as bace2 inhibitors
03/14/2012EP2427434A1 Process for preparing bromo-substituted quinolines
03/14/2012EP2284169B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders
03/14/2012EP1667685B1 Quinazoline potassium channel inhibitors
03/14/2012EP1147104B1 Aromatic heterocyclic compounds as antiinflammatory agents
03/14/2012CN102378762A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
03/14/2012CN102378758A Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
03/14/2012CN101506201B Novel heteroaryl substituted benzoxazoles
03/14/2012CN101384559B Benzimidazole derivatives and their use for modulating the GABA-A receptor complex
03/13/2012US8134021 Phosphorus-containing bisphenols and preparing method thereof
03/13/2012US8134007 Pyridine derivatives
03/13/2012US8133995 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/13/2012US8133889 Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
03/13/2012US8133888 Hydrazide containing taxane conjugates
03/13/2012US8133887 Oxaphenanthrene derivatives
03/13/2012US8133886 Heterobicyclic carboxamides as inhibitors for kinases
03/13/2012CA2685952C N- [6-amino-5- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
03/13/2012CA2565812C 4-phenylamino-quinazolin-6-yl-amides
03/08/2012WO2012031004A1 Pyridinones/pyrazinones, method of making, and method of use thereof
03/08/2012WO2012030948A1 Quinazoline compounds and methods of use thereof
03/08/2012WO2012030944A2 Quinoline and isoquinoline compounds and methods of use thereof
03/08/2012WO2012030912A1 7-cyclylquinazoline derivatives and methods of use thereof
03/08/2012WO2012030907A1 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012WO2012029070A1 Heterocyclyl compounds as histamine h3 receptor ligands
03/08/2012WO2012028629A1 2 - (benzyloxy) benzamides as lrrk2 kinase inhibitors
03/08/2012WO2012028332A1 Pharmaceutically active compounds as axl inhibitors
03/08/2012WO2011151618A3 Compounds for the treatment of clostridium difficile associated disease (cdad)
03/08/2012WO2011138427A3 Pyridazinones as gpr119 agonists
03/08/2012WO2010124121A8 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
03/08/2012WO2010094126A8 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/08/2012US20120059171 Process for Preparing Substituted Isoxazoline Compounds and Their Precursors
03/08/2012US20120059166 Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
03/08/2012US20120059165 Intermediate compound for synthesizing pharmaceutical agent and production method thereof
03/08/2012US20120059034 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
03/08/2012US20120059014 Compounds for the Treatment of Metabolic Disorders
03/08/2012US20120059004 Compounds And Compositions For Treating Cancer
03/08/2012US20120059003 Inhibitors of inv(16) leukemia
03/08/2012US20120059002 Novel anti-inflammatory agents
03/08/2012US20120059001 Novel kinase modulators
03/08/2012US20120058996 Carbazole carboxamide compounds useful as kinase inhibitors
03/08/2012US20120058988 Carbazole and carboline kinase inhibitors
03/08/2012US20120058987 Therapeutic uses of quinazolinedione derivatives
03/08/2012US20120058986 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012US20120058892 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and their use as herbicides
03/08/2012US20120058891 Oxadizine-Substituted Arylamides
03/08/2012US20120058566 Detection of immobilized nucleic acid
03/08/2012CA2812970A1 Heterocyclyl compounds as histamine h3 receptor ligands
03/08/2012CA2810024A1 Quinazoline compounds and methods of use thereof
03/08/2012CA2809991A1 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012CA2809222A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012CA2807620A1 Pharmaceutically active compounds as axl inhibitors
03/07/2012EP2426125A1 1,4 disubstituted 3 cyano pyridone derivatives and their use as positive allosteric modulators of mGluR2 receptors
03/07/2012EP2426122A1 Methylene urea derivative as RAF kinasse inhibitors
03/07/2012EP2426115A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/07/2012EP2426109A1 Novel kinase inhibitors
03/07/2012EP2426106A1 Piperidine and Piperazine derivatives for the treatment of tumours
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 647